Callan Capital LLC cut its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 7.6% during the fourth quarter, Holdings Channel reports. The firm owned 2,552 shares of the technology company’s stock after selling 210 shares during the quarter. Callan Capital LLC’s holdings in Amdocs were worth $217,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the stock. Creative Planning increased its stake in Amdocs by 37.3% in the 3rd quarter. Creative Planning now owns 15,111 shares of the technology company’s stock worth $1,322,000 after purchasing an additional 4,104 shares in the last quarter. Blue Trust Inc. increased its position in shares of Amdocs by 58.2% in the third quarter. Blue Trust Inc. now owns 1,800 shares of the technology company’s stock worth $157,000 after acquiring an additional 662 shares in the last quarter. Foundations Investment Advisors LLC acquired a new stake in shares of Amdocs during the third quarter valued at approximately $226,000. Private Advisor Group LLC raised its holdings in shares of Amdocs by 3.2% during the third quarter. Private Advisor Group LLC now owns 5,626 shares of the technology company’s stock valued at $492,000 after acquiring an additional 175 shares during the period. Finally, International Assets Investment Management LLC purchased a new stake in shares of Amdocs in the 3rd quarter valued at approximately $8,950,000. 92.02% of the stock is owned by hedge funds and other institutional investors.
Amdocs Price Performance
Shares of NASDAQ:DOX opened at $87.91 on Monday. The firm has a market cap of $9.92 billion, a price-to-earnings ratio of 20.40, a P/E/G ratio of 1.47 and a beta of 0.71. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $94.04. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The business has a fifty day simple moving average of $86.07 and a 200 day simple moving average of $86.66.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be paid a $0.527 dividend. The ex-dividend date is Monday, March 31st. This is a boost from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.40%. Amdocs’s payout ratio is 48.72%.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on DOX shares. Barclays reduced their target price on Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 19th. Finally, Oppenheimer upped their target price on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.20.
Read Our Latest Research Report on DOX
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
- Five stocks we like better than Amdocs
- High Flyers: 3 Natural Gas Stocks for March 2022
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Why Invest in 5G? How to Invest in 5G Stocks
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.